1. Home
  2. BEEM vs EVAX Comparison

BEEM vs EVAX Comparison

Compare BEEM & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

HOLD

Current Price

$1.40

Market Cap

28.6M

Sector

Technology

ML Signal

HOLD

Logo Evaxion Biotech

EVAX

Evaxion Biotech

HOLD

Current Price

$2.95

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEM
EVAX
Founded
2006
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
25.9M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
BEEM
EVAX
Price
$1.40
$2.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$3.50
$11.67
AVG Volume (30 Days)
1.4M
194.5K
Earning Date
04-09-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
40.77
N/A
EPS
N/A
N/A
Revenue
$28,236,000.00
N/A
Revenue This Year
$40.48
N/A
Revenue Next Year
$32.17
$328.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.97
$2.52
52 Week High
$4.04
$12.15

Technical Indicators

Market Signals
Indicator
BEEM
EVAX
Relative Strength Index (RSI) 54.63 43.85
Support Level $1.38 $2.91
Resistance Level $1.42 $3.62
Average True Range (ATR) 0.14 0.28
MACD 0.02 -0.02
Stochastic Oscillator 47.01 20.99

Price Performance

Historical Comparison
BEEM
EVAX

About BEEM Beam Global

Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: